Etrasimod: A New Oral Treatment Option for Ulcerative Colitis

The S1PR modulators are currently positioned to serve as a great treatment option for patients with moderate disease who are hesitant to escalate to a biologic treatment.

Related Keywords

,Pfizer ,Drug Administration ,Bristol Myers Squibb ,Qazi Corner ,Etrasimod ,Ulcerative Colitis ,Uc ,Elevate ,Ozanimod ,